Overview

EXPAREL Facia Iliaca Compartment Block for Intertrochanteric Hip Fracture

Status:
Withdrawn
Trial end date:
2020-05-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of EXPAREL on total opioid consumption through 72 hours following fascia iliaca compartment block (FICB) in subjects undergoing repair of intertrochanteric hip fracture.
Phase:
Phase 4
Details
Lead Sponsor:
Pacira Pharmaceuticals, Inc
Treatments:
Bupivacaine
Ropivacaine